Inhibition of differentiation of monocyte to macrophages in atherosclerosis by oligomeric proanthocyanidins -In-vivo and in-vitro study

Food and Chemical Toxicology

Volumn 82, Issue , 2015, Pages 96-105

  Mohana, Thiruchenduran ^a   Navin, Alukkathara Vijayan ^a   Jamuna, Sanker ^a   Sakeena Sadullah, Mohammed Sadullah ^a   Niranjali Devaraj, Sivasithamparam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Crataegus oxyacantha; Hypercholesterolemia; Monocyte differentiation; Oxidative injury; U937 cells

Indexed keywords

CATALASE; CD36 ANTIGEN; CD68 ANTIGEN; CHOLESTEROL; CHOLIC ACID; COLONY STIMULATING FACTOR 1; GELATINASE A; GELATINASE B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGOMERIC PROANTHOCYANIDIN DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROANTHOCYANIDIN DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN; ANTIOXIDANT; PROANTHOCYANIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL DIFFERENTIATION; CELL INFILTRATION; CELL VIABILITY; CHEMOPROPHYLAXIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CRATAEGUS LAEVIGATA; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BLOOD; CHEMISTRY; CRATAEGUS; CYTOLOGY; DRUG EFFECTS; HEART; HUMAN; METABOLISM; PATHOLOGY; WISTAR RAT;

CRATAEGUS MONOGYNA; RATTUS NORVEGICUS;

ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CHOLESTEROL; CRATAEGUS; HEART; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MALE; MONOCYTES; PROANTHOCYANIDINS; RATS, WISTAR;

EID: 84931261415     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.04.028     Document Type: Article

References (53)

1. Bagchi D., Sen C.K., Ray S.D., Das D.K., Bagchi M., Preuss H.G., et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat. Res 2003, 523-524:87-97. Review.
2. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
3. Blazso G., Gabor M., Sibbel R., Rohdewald P. Anti-inflammatory and superoxide radical scavenging activities of a procyanidins containing extract from the bark of Pinus pinaster Sol and its ions. Pharm. Pharmacol. Lett 1994, 3:217.
4. Burstein M., Scholnick H.R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res 1970, 11:583-595.
5. Cipollone F., Fazia M.L., Iezzi A., Cuccurullo C., De Cesare D., Ucchino S., et al. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler. Thromb. Vasc. Biol 2005, 25:1925-1931.
6. Clanchy F.I., Holloway A.C., Lari R., Cameron P.U., Hamilton J.A. Detection and properties of the human proliferative monocyte subpopulation. J. Leukoc. Biol 2006, 80:448.
7. Coimbra S., Castro E., Rocha-Pereira P., Rebelo I., Rocha S., Santos-Silva A. The effect of green tea in oxidative stress. Clin. Nutr 2006, 25:790-796.
8. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. PSelectinor intercellular adhesion molecule (ICAM)-1 deficiency substantially protectsagainst atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med 2000, 191:189-194.
9. Cooper R., Morré D.J., Morré D.M. Medicinal benefits of green tea: part I. Review of noncancer health benefits. J. Altern. Complement. Med 2005, 11:521-528.
10. Dvořáková M., Paduchová Z., Muchová J., Duračková Z., Collins A.R. How does Pycnogenol® influence oxidative damage to DNA and its repair ability in elderly people?. Prague Med. Rep 2010, 111:263-271.
11. Elango C., Jayachandaran K.S., Niranjali Devaraj S. Hawthorn extract reduces infarct volume and improves neurological score by reducing oxidative stress in rat brain following middle cerebral artery occlusion. Int. J. Dev. Neurosci 2009, 27(8):799-803.
12. Ellis A., Cheng Z.J., Li Y., Jiang Y.F., Yang J., Pannirselvam M., et al. Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature. Eur. J. Pharmacol 2008, 601:111-117.
13. Febbraio M., Hajjar D.P., Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest 2001, 108:785-791.
14. Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res 2002, 90:251-262.
15. Geiss F., Heinrich M., Hunkler D., Rimpler H. Proanthocyanidins with(+) Eepicatechin units from Byrsonima crassifolia bark. Phytochemistry 1995, 39(3):635-643.
16. Heidenreich P.A., Trogdon J.G., Khavjou O.A., Butler J., Dracup K., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123(8):933-944.
17. Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol 2001, 21(5):844-848.
18. Hort M.A., Straliotto M.R., Duz M.S., Netto P.M., Souza C.B., Schulz T., et al. Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: focus on atherosclerosis. Food Chem. Toxicol 2012, 50(10):3769-3775.
19. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res 2000, 87:179-183.
20. Irvine K.M., Andrews M.R., Fernandez-Rojo M.A., Schroder K., Burns C.J., Su S., et al. Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J. Leukoc. Biol 2009, 85:278-288.
21. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol. Pharm. Bull 2003, 26(1):1-9. Review.
22. Jayachandran K.S., Khan M., Karuppaiyah S., Niranjali Devaraj S., Brian K., Kuppusamy P. Crataegus oxyacantha extract reduces apoptotic incidence in an experimental myocardial ischemic/reperfusion model by regulation Akt and HIF-1 signaling pathways. J. Cardiovasc. Pharmacol 2010, 56:526-531.
23. Jayalakshmi R., Thirupurasundari C.J., Devaraj S.N. Pretreatment with alcoholic extract of Crataegus oxyacantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats. Mol. Cell. Biochem 2006, 292(1-2):59-67.
24. Kaptanoglu E., Sen S., Beskonakli E., et al. Antioxidant actions and early ultrastructural findings of thiopental and propofol in experimental spinal cord injury. J. Neurosurg. Anesthesiol 2002, 14:114-122.
25. Kita T., Kume N., Minami M., Hayashida K., Murayama T., Sano H. Role of oxidized LDL in atherosclerosis. Ann. N.Y. Acad. Sci 2001, 947:199-205.
26. Kumar V., Rani A., Dixit A.K., Bhatnagar D., Chauhan G.S. Relative changes in tocopherols, isoflavones, total phenolic content, and antioxidative activity in soybean seeds at different reproductive stages. J. Agric. Food Chem 2009, 57:2705-2710.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 277:680-685.
28. Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr 2006, 83(2):456S-460S. Review.
29. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F. Protective role of interleukin-10 in atherosclerosis. Circ. Res 1999, 85:e17-e24.
30. Manickam A., Halagowder D. Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats. Vascul. Pharmacol 2008, 49(4-6):173-177.
31. Nicholson A.C., Han J., Febbraio M., Silversterin R.L., Hajjar D.P. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann. N.Y. Acad. Sci 2001, 947:224-228.
32. Nievelstein P.F.E.M., Fogelman A.M., Mottino G., Frank J.S. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein: a deep-etch and immunolocalization study of rapidly frozen tissue. Arterioscler. Thromb 1991, 11:1795-1805.
33. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev 2003, 83:1069-1112.
34. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem 2008, 54:24-38.
35. Parekh A.C., Jung D.H. Cholesterol determination with ferric acetate-uranyl acetate sulphuric acid, ferrous sulphate reagents. Anal. Chem 1970, 42:1423-1427.
36. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004, 14:628-638.
37. Richardson M., Hadcock S.J., DeReske M., Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb 1994, 14:760-769.
38. Sano T.E., Oda T., Yamashita T., Naemura A., Ijiri Y., Yamakoshi J., et al. Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed. Thomb. Res 2005, 115:115-121.
39. Schoen F.J. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc. Pathol 2005, 14:189-194.
40. Seta N., Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J. Med 2007, 56:41-47.
41. Steinbrecher U.P., Zhang H.F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med 1990, 9(2):155-168. Review.
42. Svedström U., Vuorela H., Kostiainen R., Huovinen K., Laakso I., Hiltunen R. High-performance liquid chromatographic determination of oligomeric procyanidins from dimers up to the hexamer in Hawthorn. J. Chromatogr. A 2002, 968:53-60.
43. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4350-4354.
44. Triggiani M., Petraroli A., Loffredo S., Frattini A., Granata F., Morabito P., et al. Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. J. Allergy Clin. Immunol 2007, 119:472-481.
45. Vibes J., Lasserre B., Gleye J., Declume C. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crataegus oxyacantha (Hawthorn) flower heads. Prostaglandins Leukot. Essent. Fatty Acids 1994, 50(4):173-175.
46. Vijayan N.A., Thiruchenduran M., Devaraj S.N. Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage. Mol. Cell. Biochem 2012, 367:1-8.
47. Waldo S.W., Li Y., Buono C., Zhao B., Billings E.M., Chang J., et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol 2008, 172:1112-1126.
48. Wallin B., Rosengren B., Shertzer H.G., Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtitre plate: its use for evaluation of antioxidants. Anal. Biochem 1993, 208:10-15.
49. Weydert C.J., Cullen J.J. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat. Protoc 2010, 5:51-66.
50. Wilson D.E., Spiger M.J. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med 1973, 82(3):473-482.
51. Wittchen E.S. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front. Biosci 2009, 14:2522-2545.
52. Xu J., Gao H., Zhang L., Chen C., Yang W., Deng Q., et al. A combination of flaxseed oil and astaxanthin alleviates atherosclerosis risk factors in high fat diet fed rats. Lipids Health Dis 2014, 13:63.
53. Zal B., Kaski J.C., Arno G., Akiyu J.P., Xu Q., Cole D., et al. Heat-shock protein 60-reactive CD4+CD28-null T cells in patients with acute coronary syndromes. Circulation 2004, 109(10):1230-1235.